These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Butazolidin ointment in orthopedic traumatologic practice]. Grobelnik S Reumatizam; 1966; 13(4):142-4. PubMed ID: 5922594 [No Abstract] [Full Text] [Related]
4. [Vasotonin forte-serol in the therapy of the inflamed joint]. Schmidt G Landarzt; 1967 Feb; 43(4):179-80. PubMed ID: 5597234 [No Abstract] [Full Text] [Related]
5. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. Mizushima Y; Shiokawa Y; Honma M; Kageyama T Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427 [TBL] [Abstract][Full Text] [Related]
6. [Initial results of utilization of an anti-inflammatory ointment combining phenylbutazone and alphachymotrypsin in orthopedic surgery]. Gacon G Lyon Med; 1969 Nov; 222(43):997-1000. PubMed ID: 5375671 [No Abstract] [Full Text] [Related]
7. [Hexahydropyrazine salt of phenylbutazone in O.R.L]. Laccourreye H Ann Otolaryngol Chir Cervicofac; 1970 Jun; 87(6):397-402. PubMed ID: 5424469 [No Abstract] [Full Text] [Related]
8. [Recent acquisitions in anti-inflammatory therapy in rheumatology]. Saporta L; Massias P Therapeutique; 1970 Nov; 46(9):937-9. PubMed ID: 5486145 [No Abstract] [Full Text] [Related]
9. [Clinical observations on the use of a new anti-inflammatory analgesic in the obstetric-gynecologic field]. Iurlaro F Minerva Ginecol; 1966 May; 18(9):468-73. PubMed ID: 5951584 [No Abstract] [Full Text] [Related]
10. [Treatment of inflammatory adnexal diseases of women with Irgapyrin]. Silomon R Med Welt; 1969 Nov; 48():2649-51. PubMed ID: 5386516 [No Abstract] [Full Text] [Related]
11. [Concentrations of phenylbutazone in the blood following use of Butazolidin ointment]. Hansen EC; Nielsen E Ugeskr Laeger; 1972 Jan; 134(5):208-10. PubMed ID: 5010808 [No Abstract] [Full Text] [Related]
12. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology]. Portmann M; Pardes P Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287 [No Abstract] [Full Text] [Related]
13. [Use of phenylbutazone combined with deglycerinated liquorice juice in postoperative care following tonsillectomy and adenoidectomy]. Calvet J; Torossian F Clin Otorinolaringoiatr; 1969; 21(5):319-25. PubMed ID: 5405073 [No Abstract] [Full Text] [Related]
14. [ON THE EFFECT OF BUTAZOLIDIN IN OINTMENT FORMS]. OBERUECK O Med Welt; 1964 Jun; 25():1383-4. PubMed ID: 14248673 [No Abstract] [Full Text] [Related]
15. [Combined effect of an unspecific anti-inflammatory agent (hydroxyphenylbutazone) with primary reaction drugs]. Baruffi W; Fadel JC; Mendes IF; Machado FS; Gay D Hospital (Rio J); 1968 Oct; 74(4):1343-59. PubMed ID: 5304817 [No Abstract] [Full Text] [Related]
16. [Clinical study of bufexamac ointment in gynecology and obstetrics]. Florence N Brux Med; 1972 Mar; 52(3):209-13. PubMed ID: 5022752 [No Abstract] [Full Text] [Related]
17. Migraine headache:--the prophylactic role of an isopyrin-phebuzine compound (Tomanol). Mamvura CB Cent Afr J Med; 1983 Oct; 29(10):200-1. PubMed ID: 6607774 [No Abstract] [Full Text] [Related]
18. Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea. Furniss LD Clin Pharm; 1982; 1(4):327-33. PubMed ID: 6764392 [TBL] [Abstract][Full Text] [Related]
19. [On the antiphogistic properties of some derivatives of phenylbutazone]. Schönhöfer P; Ojinmah N Med Pharmacol Exp Int J Exp Med; 1967; 16(6):536-44. PubMed ID: 6072431 [No Abstract] [Full Text] [Related]